The Food and Drug Administration (FDA) is studying the health risks associated with two popular birth control pills. The birth control pills Yaz and Yasmin are manufactured by Bayer Pharmaceuticals and contain the active ingredient drospirenone. The FDA announced the warning after two new studies reported a 2 to 3 times greater risk of venous thromboembolism (VTE) in women using birth control containing drospirenone.
VTE AND OTHER YAZ SIDE EFFECTS NOTED
Two recent studies published in the British Medical Journal raised concerns that contraceptives containing Drospirenone increase the risk of VTE. VTE is a blood clot that forms in a vein, and includes deep venous thrombosis (DVT) and pulmonary embolism. Along with the increased risk of blood clots, other side effects include: stroke, heart attack, headache/migraine, menstrual irregularities, nausea/vomiting, breast pain/tenderness, and mood changes.
YAZ AND YASMIN BY BAYER
The FDA approved Yasmin in 2001 and Yaz in 2006. Both drugs use the combination of Drospirenone and Ethinyl Estradiol to prevent ovulation. Yaz and Yasmin are also sold under the names Ocella, Safyral, Gianvi, & Beyaz. In 2008, the FDA sent a warning letter to Bayer after commercials for Yaz overstated the drug’s effectiveness, minimized the risks associated with its use, and “encourage[d] use of Yaz in circumstances other than those in which the drug has been approved.” Then in 2009, the FDA sent another warning letter to Bayer after several problems were identified in the manufacturing process of Drospirenone.
YAZ ATTORNEYS AT ATKINS & MARKOFF CAN HELP SIDE EFFECT VICTIMS
Blood clots caused by birth control can create serious health issues and may even be fatal. If you or someone you love has used Yaz or Yasmin and suffered a blood clot, stroke, heart attack, or other injuries, contact the defective drug attorneys at Atkins & Markoff today. Our Yaz lawsuit attorneys have years of experience in defective drug litigation and will be happy to discuss your case with you.